Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats.
D000085:Acetates / Q000378:metabolism*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism* / Q000494:pharmacology; D001168:Arthritis / Q000378:metabolism*; D001169:Arthritis, Experimental / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism; D002087:Butyrates / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors; D017308:Etodolac; D007210:Indoleacetic Acids; D007211:Indoles / Q000378:metabolism; D007700:Kinetics; D008297:Male; D011485:Protein Binding; D011714:Pyrans / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution
D000085:Acetates; D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D002087:Butyrates; D016861:Cyclooxygenase Inhibitors; D007210:Indoleacetic Acids; D007211:Indoles; D011714:Pyrans; D017308:Etodolac; C033631:AY 23427; C007803:furobufen; C009795:prodolic acid